Advertisement
The Journal of Heart and Lung Transplantation
International Society for Heart and Lung Transplantation.

The ADHF/NT-proBNP risk score to predict 1-year mortality in hospitalized patients with advanced decompensated heart failure

Published:December 18, 2013DOI:https://doi.org/10.1016/j.healun.2013.12.005

      Background

      The acute decompensated heart failure/N-terminal pro-B-type natriuretic peptide (ADHF/NT-proBNP) score is a validated risk scoring system that predicts mortality in hospitalized heart failure patients with a wide range of left ventricular ejection fractions (LVEFs). We sought to assess discrimination and calibration of the score when applied to patients with advanced decompensated heart failure (AHF).

      Methods

      We studied 445 patients hospitalized for AHF, defined by the presence of severe symptoms of worsening HF at admission, severely depressed LVEF, and the need for intravenous diuretic and/or inotropic drugs. The primary outcome was cumulative (in-hospital and post-discharge) mortality and post-discharge 1-year mortality. Separate analyses were performed for patients aged ≤ 70 years. A Seattle Heart Failure Score (SHFS) was calculated for each patient discharged alive.

      Results

      During follow-up, 144 patients (32.4%) died, and 69 (15.5%) underwent heart transplantation (HT) or ventricular assist device (VAD) implantation. After accounting for the competing events (VAD/HT), the ADHF/NT-proBNP score’s C-statistic for cumulative mortality was 0.738 in the overall cohort and 0.771 in patients aged ≤ 70 years. The C-statistic for post-discharge mortality was 0.741 and 0.751, respectively. Adding prior (≤6 months) hospitalizations for HF to the score increased the C-statistic for post-discharge mortality to 0.759 in the overall cohort and to 0.774 in patients aged ≤ 70 years. Predicted and observed mortality rates by quartiles of score were highly correlated. The SHFS demonstrated adequate discrimination but underestimated the risk. The ADHF/NT-proBNP risk calculator is available at http://www.fsm.it/fsm/file/NTproBNPscore.zip.

      Conclusions

      Our data suggest that the ADHF/NT-proBNP score may efficiently predict mortality in patients hospitalized with AHF.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to The Journal of Heart and Lung Transplantation
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Nieminen M.S.
        • Brutsaert D.
        • Dickstein K.
        • et al.
        EuroHeart Failure Survey II (EHFS II): a survey on hospitalized acute heart failure patients: description of population.
        Eur Heart J. 2006; 27: 2725-2736
        • Fonarow G.C.
        • Abraham W.T.
        • Albert N.
        • et al.
        Day of admission and clinical outcomes for patients hospitalized for heart failure: findings from the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients With Heart Failure (OPTIMIZE-HF).
        Circ Heart Fail. 2008; 1: 50-57
      1. Lloyd-Jones D, Adams RJ, Brown TM, et al. Heart disease and stroke statistics—2010 update: a report from the American Heart Association. Circulation 2010;121:e46–215.

        • Maggioni A.P.
        • Dahlström U.
        • Filippatos
        • et al.
        EURObservational Research Programme: the Heart Failure Pilot Survey (ESC-HF Pilot).
        Eur J Heart Fail. 2010; 12: 1076-1084
        • Adams K.F.
        • Fonarow G.C.
        • Emerman C.
        • et al.
        Characteristics and outcomes of patients hospitalized for heart failure in the United States: rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE).
        Am Heart J. 2005; 149: 209-216
        • Blair J.E.A.
        • Zannad F.
        • Konstam M.A.
        • et al.
        Continental differences in clinical characteristics, management, and outcomes in patients hospitalized with worsening heart failure.
        J Am Coll Cardiol. 2008; 52: 1640-1648
        • Tavazzi L.
        • Maggioni A.P.
        • Lucci D.
        • et al.
        Nationwide survey on acute heart failure in cardiology ward services in Italy.
        Eur Heart J. 2006; 27: 1207-1215
        • O’Connor C.M.
        • Hasselblad V.
        • Mehta R.H.
        • et al.
        Triage after hospitalization with advanced heart failure: The ESCAPE (Evaluation Study of Congestive Heart Failure and Pulmonary Artery Catheterization Effectiveness) risk model and discharge score.
        J Am Coll Cardiol. 2010; 55: 872-878
        • Setoguchi S.
        • Stevenson L.W.
        • Schneeweiss S.
        Repeated hospitalizations predict mortality in the community population with heart failure.
        Am Heart J. 2007; 154: 260-266
        • Tavazzi L.
        • Senni M.
        • Metra M.
        Multicenter prospective observational study on acute and chronic heart failure: one-year follow-up results of IN-HF (Italian Network on Heart Failure) outcome registry.
        Circ Heart Fail. 2013; 6: 473-481
        • Abrahamsson P.
        • Swedberg K.
        • Borer J.S.
        • et al.
        Risk following hospitalization in stable chronic systolic heart failure.
        Eur J Heart Fail. 2013; 15: 885-891
        • Stewart G.C.
        • Givertz M.M.
        Mechanical Circulatory support for advanced heart failure: patients and technology in evolution.
        Circulation. 2012; 125: 1304-1315
        • Allen L.A.
        • Stevenson L.X.
        • Grady K.L.
        • et al.
        Decision making in advanced heart failure. a scientific statement from the American Heart Association.
        Circulation. 2012; 125: 1928-1952
        • Allen L.A.
        • Gheorghiade M.
        • Reid K.
        • et al.
        Identifying patients hospitalized with heart failure at risk for unfavorable future quality of life.
        Circ Cardiovasc Qual Outcomes. 2011; 4: 389-398
        • Gorodeski E.Z.
        • Chu E.C.
        • Chow C.H.
        • Levy W.C.
        • Hsich E.
        • Starling R.C.
        Application of the Seattle Heart Failure Model in ambulatory patients presented to an advanced heart failure therapeutics committee.
        Circ Heart Fail. 2010; 3: 706-714
        • Kalogeropoulos A.P.
        • Georgiopoulou V.V.
        • Giamouzis G.
        • et al.
        Utility of the Seattle Heart Failure Model in patients with advanced heart failure.
        J Am Coll Cardiol. 2009; 53: 334-342
        • Scrutinio D.
        • Ammirati E.
        • Guida P.
        • et al.
        Clinical utility of N-terminal pro-B-type natriuretic peptide for risk stratification of patients with acute decompensated heart failure. Derivation and validation of the ADHF/NT-proBNP risk score.
        Int J Cardiol. 2013; 168: 2120-2126
        • Putter H.
        • Fiocco M.
        • Geskus R.B.
        Tutorial in biostatistics: competing risks and multi-state models.
        Stat Med. 2007; 26: 2389-2430
        • Miller L.W.
        Is left ventricular assist device therapy underutilized in the treatment of heart failure?: left ventricular assist devices are underutilized.
        Circulation. 2011; 123: 1552-1558
        • Hosmer D.W.
        • Lemeshow S.
        Applied survival analysis.
        Regression modeling of time to event data. John Wiley & Sons Inc, New York, NY2000
        • Levy W.C.
        • Mozaffarian D.
        • Linker D.T.
        • et al.
        The Seattle Heart Failure Model. Prediction of survival in heart failure.
        Circulation. 2006; 113: 1424-1433
        • Heart Failure Society of America
        Executive summary: HFSA 2010 Comprehensive Heart Failure Practice Guideline.
        J Card Fail. 2010; 16: 475-539
        • Jessup M.
        • Abraham W.T.
        • Casey D.E.
        • et al.
        2009 focused update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the International Society for Heart and Lung Transplantation.
        Circulation. 2009; 119: 1977-2016
        • Miller L.W.
        • Guglin M.
        Patient selection for ventricular assist devices.
        A moving target. J Am Coll Cardiol. 2013; 61: 1209-1221
        • Feldman D.
        • Pamboukian S.V.
        • Teuteberg J.J.
        • et al.
        The 2013 International Society for Heart and Lung Transplantation Guidelines for Mechanical Circulatory Support: executive summary.
        J Heart Lung Transpl. 2013; 32: 157-187
        • Levy W.C.
        • Mozaffarian D.
        • Linker D.T.
        • Farrar D.J.
        • Miller L.W.
        • on behalf of the REMATCH Investigators
        Can the Seattle Heart Failure Model be used to risk-stratify heart failure patients for potential left ventricular assist device therapy?.
        J Heart Lung Transplant. 2009; 28: 231-236
        • Baldwin J.T.
        • Douglas L.M.
        NHLBI’s program for VAD intervention for moderately advanced heart failure.
        The REVIVE-IT pilot trial. J Card Fail. 2010; 16: 855-858
        • Goda A.
        • Williams P.
        • Mancini D.
        • Lund L.H.
        Selecting patients for heart transplantation: comparison of the Heart Failure Survival Score (HFSS) and the Seattle Heart Failure Model (SHFM).
        J Heart Lung Transplant. 2011; 30: 1236-1243
        • Adlbrecht C.
        • Hülsmann M.
        • Neuhold S.
        • Strumk G.
        • Pacher R.
        Prognostic utility of the Seattle Heart Failure Score and amino-terminal pro B-type natriuretic peptide in varying stages of systolic heart failure.
        J Heart Lung Transplant. 2013; 32: 533-538
        • Ketchum E.S.
        • Levy W.C.
        Multivariate risk scores and patient outcomes in advanced heart failure.
        Congest Heart Fail. 2011; 17: 205-212
        • Steyerberg E.W.
        • Harrell Jr, F.E.
        • Borsboom G.J.
        • Eijkemans M.J.
        • Vergouwe Y.
        • Habbema J.D.
        Internal validation of predictive models: efficiency of some procedures for logistic regression analysis.
        J Clin Epidemiol. 2001; 54: 774-781
        • Altman D.G.
        • Royston P.
        What do we mean by validating a prognostic model?.
        Stat Med. 2000; 19: 453-473